Study on Pidotimune as immune modulator in covid patients

Authors

  • Dr. Vamshi Keshvaram, Dr. Surender Reddy, Dr. Mohammed Abdul Naseer Author

DOI:

https://doi.org/10.48047/

Abstract

Aim: In this study, patients with COVID-19 were examined for the safety and effectiveness
of pidotimod as an immune modulator. A synthetic dipeptide drug "pidotimod" is believed to
strengthen the immune system, which could lessen the severity of COVID-19 symptoms and
improve patient outcomes

Downloads

Download data is not yet available.

Downloads

Published

2024-07-16

Issue

Vol. 15 No. 7 (2024): volume 15 issue 7 (2024)

Section

Articles